Evidence map›Paper›PMID 42291025›Full record

ArticleAmerican journal of preventive cardiology2026

Systematic examination of the PREVENT equations for cardiovascular disease risk.

Vaishnavi Krishnan, Xiaoning Huang, Chiadi E Ndumele, Janani Rangaswami, Josef Coresh, Amanda M Perak, Nilay S Shah, Donald M Lloyd-Jones, Sadiya S Khan

Abstract read
In one paragraph

Article in American journal of preventive cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Vaishnavi KrishnanDivision of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Xiaoning HuangDivision of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Chiadi E NdumeleDivision of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Janani RangaswamiWashington DC VA Medical Center and George Washington University School of Medicine, WA D.C, USA.
Josef CoreshDepartment of Population Health, New York University Grossman School of Medicine, NY, NY, USA.
Amanda M PerakDepartment of Preventive Medicine, Northwestern University, Chicago, IL, USA.
Nilay S ShahDivision of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Donald M Lloyd-JonesSection of Preventive Medicine & Epidemiology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Sadiya S KhanDivision of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The Predicting Risk of cardiovascular disease (CVD) EVENTs (PREVENT) equations accurately estimate CVD risk, but how different combinations of ages and risk factors translate into risk estimates, including combinations required to meet clinically meaningful risk thresholds, is not intuitive. Methods: We calculated sex-specific estimatesion of 10-year risk of total CVD (composite of atherosclerotic CVD and heart failure) for a hypothetical person between the ages of 30-79 years with the PREVENT-CVD base equations and varied individual or multiple risk factors simultaneously, with all other risk factor levels set at sex-specific, population-based average values. Next, we examined how specific age and risk factor combinations would exceed clinically-meaningful thresholds. Secondary analyses included the PREVENT-CVD equations with add-on predictors and the 30-year PREVENT-CVD equations. Results: Ten-year risk estimates for a hypothetical person with average risk factor levels ranged from 0.3 %-17.4 % for a female and 0.7 %-22.8 % for a male with the PREVENT-CVD base equations, exceeding the clinically-relevant risk threshold of ≥7.5 % at age 68 years if female and at age 63 years if male. Additionally, a hypothetical person with Stage 3 CKD and diabetes would exceed the 10-year risk threshold of ≥7.5 % with the PREVENT-CVD equations at age 43 years if female and at age 36 years if male. Similar patterns were observed with add-on predictor equations. With average risk factor levels, 30-year PREVENT-CVD risk estimates ranged from 2.5 %-20.5 % for a female and 4.8 %-26.5 % for a male. Conclusions: These results can support clinicians and patients in the interpretability of the PREVENT equations and can inform clinician-patient discussions on preventive efforts.

Indexed as

Cardiovascular disease riskCKM healthRisk communication

Identifiers

PMID42291025
PMCPMC13261269

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.